(Q44505422)

3 December 2017

title

Is it time to conclude that NMDA antagonists have failed? (English)

1 reference

3 December 2017

2

1 reference

ORCID Public Data File 2021

3 December 2017

1 reference

author name string

Rafael Roesler

series ordinal

1

1 reference

3 December 2017

Nadja Schröder

series ordinal

3

1 reference

3 December 2017

publication date

1 January 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

2

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

13; discussion 13

1 reference

Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900260-6

7 January 2021

NMDA receptor pathways as drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900260-6

7 January 2021

Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900260-6

7 January 2021

d-Cycloserine enhances implicit memory in Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900260-6

7 January 2021

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900260-6

7 January 2021

10.1016/S1474-4422(03)00260-6

Identifiers

DOI

1 reference

3 December 2017

1 reference